Novel therapies for childhood cancer and impact on puberty

Endocrine late effects are common sequelae of the treatment of childhood cancer, and surveillance and management of these are integral to the follow-up of childhood cancer survivors. Cancer treatments are evolving to improve survival and minimize toxicities, and novel treatment modalities such as proton radiotherapy and immunotherapies are becoming available. Recognising reduced endocrine sequelae to lower intensity treatments and potential...